Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAMP: Safety of Tranexamic Acid in Meningioma Resection
NCT04595786Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Oct 2020
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in meningioma comparing TXA group with Placebo group (2 arms). Primary endpoint: Early postoperative seizures within 7 days. Started Oct 2020; status: completed.
02
Drugs
tranexamic acid
03
Conditions
meningioma
Beyond the preview
Go deeper on NCT04595786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04595786.